EUVIMEDEUVIMED entdecken
Crossref

Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection

Yixia Yang, Qingming Pan, Minling Liu, Leli Zeng iD, Hailin Zou, Shuhao Liu, Shuying Fu, Yuzhi Xu iD, Zong Dai iD, Shuo Fang, Yihang Pan

Analytical Chemistry · 2026

DOI: 10.1021/acs.analchem.6c02601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Yixia Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Digestive Cancer Research, Department of Oncology, Department of Dermatovenereology, The Biobank, Scientific R…. Hauptthemen laut MEDLINE: MicroRNAs, Liquid Biopsy, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Special Project for Research and Development in Key areas of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province, Shenzhen Medical Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsLiquid BiopsyNeoplasmsCRISPR-Cas SystemsBiosensing TechniquesHumans

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Digestive Cancer Research, Department of Oncology, Department of Dermatovenereology, The Biobank, Scientific Research Center, The Seventh Affiliated Hospital, School of Medicine, S…
  • Gastrointestinal Hernia Surgery, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China.
  • School of Biomedical Engineering, Sun Yat-Sen University, Shenzhen Campus of Sun Yat-Sen University, Shenzhen 518107, China.

ORCID-Profile: Leli Zeng, Yuzhi Xu, Zong Dai

Förderung

  • Special Project for Research and Development in Key areas of Guangdong Province
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Shenzhen Medical Research Fund
  • Shenzhen Science and Technology Innovation Commission
  • National Natural Science Foundation of China (NSFC)
  • Seventh Affiliated Hospital, Sun Yat-sen University

Zitieren

APA

Yang, Y., Pan, Q., Liu, M., Zeng, L., Zou, H., Liu, S., Fu, S., Xu, Y., Dai, Z., Fang, S., & Pan, Y. (2026). Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c02601

Vancouver

Yang Y, Pan Q, Liu M, Zeng L, Zou H, Liu S, et al. Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c02601

BibTeX
@article{Yang2026,
  author = {Yang, Yixia and Pan, Qingming and Liu, Minling and Zeng, Leli and Zou, Hailin and Liu, Shuhao and Fu, Shuying and Xu, Yuzhi and Dai, Zong and Fang, Shuo and Pan, Yihang},
  title = {Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection},
  journal = {Analytical Chemistry},
  year = {2026},
  doi = {10.1021/acs.analchem.6c02601}
}
Kostenlos starten →